20
International Medication Systems Ltd, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is VASOPRESSIN USP, with a corresponding US DMF Number 32769.
Remarkably, this DMF maintains an Active status since its submission on May 05, 2018, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of July 13, 2018, and payment made on May 04, 2018, indicating their dedication to facilitating drug approvals, Categorized as Type II